
Sign up to save your podcasts
Or


Drs. Alison Watson and Seanna Grob review recent data on teprotumumab, the only FDA-approved therapy for thyroid eye disease.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
By American Academy of Ophthalmology4.9
5050 ratings
Drs. Alison Watson and Seanna Grob review recent data on teprotumumab, the only FDA-approved therapy for thyroid eye disease.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

43 Listeners

17 Listeners

5 Listeners

276 Listeners

8 Listeners

10 Listeners

21 Listeners

10 Listeners

10 Listeners

16 Listeners

18 Listeners

0 Listeners

1 Listeners

19 Listeners

3 Listeners